Spectral and inhibitory interactions of (±)−3, 4-methylenedioxyamphetamine (MDA) and (±)−3, 4-methylenedioxymethampetamine (MDMA) with rat hepatic microsomes☆
References (32)
- et al.
Eur. J. Pharm.
(1986) Pharmac. Ther. Part A
(1977)- et al.
Bioch. Pharm.
(1979) - et al.
Life Sci.
(1974) - et al.
Expt. Pharmacol.
(1970) Meth. Enzymol.
(1978)- et al.
J. Biol. Chem.
(1964) - et al.
J. Biol. Chem.
(1979) - et al.
Life Sci.
(1971)
J. Biol. Chem.
(1980)
Pharmacol. Biochem. Behav.
(1984)
Chem. Eng. News
(1985)
Newsweek
(April 15, 1985)
Science
(1985)
Cited by (17)
Therapeutic effects of methimazole on 3,4-methylenedioxymethamphetamine-induced hyperthermia and serotonergic neurotoxicity
2023, Biomedicine and PharmacotherapyInteractions of amphetamine analogs with human liver CYP2D6
1997, Biochemical PharmacologyFurther studies on N-methyl-1(3, 4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: Antagonism by 5-hydroxytryptamine<inf>3</inf> antagonists
1992, Pharmacology, Biochemistry and BehaviorInvestigation of MDMA-related agents in rats trained to discriminate MDMA from saline
1992, Pharmacology, Biochemistry and BehaviorEffects of MDA on classical conditioning of the rabbit nictitating membrane response
1991, Pharmacology, Biochemistry and Behavior
- ☆
Supported in part by USPHS grants CA9030 and DA02411.
Copyright © 1986 Published by Elsevier Inc.